Growth differentiation factor 15 in cardiovascular diseases: from bench to bedside
- PMID: 21718220
- DOI: 10.3109/1354750X.2011.580006
Growth differentiation factor 15 in cardiovascular diseases: from bench to bedside
Abstract
Context: Growth differentiation factor 15 (GDF-15) is a novel cytokine showing close association with cardiovascular diseases. The biological mechanism and clinical use of GDF-15 in cardiovascular diseases have been well demonstrated. We review recent investigations from both basic research and clinical trials into the biological role of GDF-15.
Methods: The data were obtained mainly from MedLine via PubMed and from our own investigations.
Results: Laboratory investigations revealed that GDF-15 has biphasic effects on cellular survival by several signaling pathways. GDF-15 participates in several cardiovascular pathological processes such as cardiac remodeling, ischemia/reperfusion injury and atherosclerotic plaque formation. As well, GDF-15 was found a prognostic biomarker of heart failure and acute coronary syndrome. The evidence for diagnostic or therapeutic utility is poor.
Conclusion: GDF-15 has great potential as a biomarker in cardiovascular diseases, especially for prognosis, and is seen as a myocardial protective cytokine, but the exact mechanism of GDF-15 in cardiovascular diseases remains unknown.
Similar articles
-
Growth-differentiation factor 15 as predictor of mortality in acute reperfused ST-elevation myocardial infarction: insights from cardiovascular magnetic resonance.Heart. 2011 Apr;97(8):632-40. doi: 10.1136/hrt.2010.219543. Epub 2011 Feb 22. Heart. 2011. PMID: 21345844 Clinical Trial.
-
Growth differentiation factor-15 as a prognostic marker in patients with acute myocardial infarction.Eur Heart J. 2009 May;30(9):1057-65. doi: 10.1093/eurheartj/ehn600. Epub 2009 Jan 23. Eur Heart J. 2009. PMID: 19168526
-
Prognostic utility of growth differentiation factor-15 in patients with chronic heart failure.J Am Coll Cardiol. 2007 Sep 11;50(11):1054-60. doi: 10.1016/j.jacc.2007.04.091. Epub 2007 Aug 24. J Am Coll Cardiol. 2007. PMID: 17825714
-
Stress-induced growth-differentiation factor 15 plays an intriguing role in cardiovascular diseases.Chin Med J (Engl). 2013 Apr;126(7):1350-4. Chin Med J (Engl). 2013. PMID: 23557570 Review.
-
[Growth differentiation factor 15--a new marker in heart diseases].Pol Merkur Lekarski. 2010 Jun;28(168):470-2. Pol Merkur Lekarski. 2010. PMID: 20642107 Review. Polish.
Cited by
-
Cardiometabolic Co-morbidity Burden and Circulating Biomarkers in Patients With Chronic Coronary Disease in the ISCHEMIA Trials.Am J Cardiol. 2024 Aug 15;225:118-124. doi: 10.1016/j.amjcard.2024.05.033. Epub 2024 Jun 4. Am J Cardiol. 2024. PMID: 38844195 Clinical Trial.
-
Growth/differentiation factor 15 (GDF15) expression in the heart after myocardial infarction and cardioprotective effect of pre-ischemic rGDF15 administration.Sci Rep. 2024 Jun 5;14(1):12949. doi: 10.1038/s41598-024-63880-5. Sci Rep. 2024. PMID: 38839839 Free PMC article.
-
Senescence-Associated Alterations in Matrisome of Mesenchymal Stem Cells.Int J Mol Sci. 2024 May 14;25(10):5332. doi: 10.3390/ijms25105332. Int J Mol Sci. 2024. PMID: 38791371 Free PMC article.
-
Correlations of Plasma Biomarkers and Imaging Characteristics of Cerebral Small Vessel Disease.Brain Sci. 2024 Mar 12;14(3):269. doi: 10.3390/brainsci14030269. Brain Sci. 2024. PMID: 38539657 Free PMC article. Review.
-
GDF-15: a novel biomarker of heart failure predicts short-term and long-term heart-failure rehospitalization and short-term mortality in patients with acute heart failure syndrome.BMC Cardiovasc Disord. 2024 Mar 12;24(1):151. doi: 10.1186/s12872-024-03802-5. BMC Cardiovasc Disord. 2024. PMID: 38475710 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
